Back to search
FDAFDA · Food and drugs·Recall number Z-0513-2014

Thermo Fisher Scientific/Microgenics brand CEDIA Tobramycin II Assay, Catalog Number 100018, Product is manufactured and distributed by Microgenics Corporation, located at Fremont, CA., part of Thermo Fisher Scientific The CEDIA Tobramycin II Assay is an in vitro diagnostic medical device intended for the quantitation of Tobramycin in human serum or plasma.

Published December 25, 2013 · Recall initiated: October 16, 2013

Summary

FDA records medical device Class II recall Z-0513-2014, published December 25, 2013 and initiated October 16, 2013. Recalling firm: Microgenics Corp; Status: Terminated; Reported quantity: 370 units; Lot: Lot Number: 60169764. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Microgenics Corp., part of Thermo Fisher Scientific, is recalling CEDIA Tobramycin II Assay (Lot Number: 60169764) due to calibration stability problem relating to two complaints received.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Microgenics Corp
Distributor
Worldwide Distribution - USA including WI, UT, ND, MT, WA, CA, OK and Internationally to Australia, Canada, and Germany.
Lot
Lot Number: 60169764
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Thermo Fisher Scientific/Microgenics brand CEDIA Tobramycin II Assay, Catalog Number 100018, Product is manufactured and distributed by Microgenics Corporation, located at Fremont, CA., part of Thermo Fisher Scientific The CEDIA Tobramycin II Assay is an in vitro diagnostic medical device intended for the quantitation of Tobramycin in human serum or plasma. recalled?

Yes. FDA published recall Z-0513-2014 on December 25, 2013. Reported hazard: Microgenics Corp., part of Thermo Fisher Scientific, is recalling CEDIA Tobramycin II Assay (Lot Number: 60169764) due to calibration stability problem relating to two complaints received.

What should I do if I have this product?

Voluntary: Firm initiated · Letter